Study design: A face-to-face interview survey. Objective: To compare bowel care patterns in spinal cord injury (SCI) patients based on type of neurogenic bowel. Setting: Department of Physical Medicine and Rehabilitation of a tertiary university hospital in Suwon, Korea. Methods: Among chronic SCI patients, 22 patients with upper motor neuron bowel (UMNB) and 20 patients with lower motor neuron bowel (LMNB) participated in an interview survey for the evaluation of bowel care patterns.
Introduction
The eects of neurogenic bowel on the quality of life after spinal cord injury (SCI) are signi®cant:
1 ± 11 27% to 90% of SCI patients reported that problems related with their neurogenic bowel signi®cantly aected their quality of life. 7,12 ± 14 Moreover, SCI patients rated the magnitude of their bowel dysfunction higher than that of their urinary problems in one report. 13 Traditionally, neurogenic bowel after SCI can be classi®ed into two types: upper motor neuron bowel (UMNB) and lower motor neuron bowel (LMNB). UMNB results from a lesion of the spinal cord above the conus medullaris. LMNB represents a pattern of colonic dysfunction resulting from a lesion aecting parasympathetic cell bodies at the conus, their axons in the cauda equina, or the pelvic nerve. The basic dierences are the presence of spinal cord-mediated re¯ex peristalsis and the integrity of the pudendal nerve. 15 During the management of neurogenic bowel in patients with SCI, we noticed signi®cant dierences in bowel care patterns between the two types of neurogenic bowel, which would thus require dierent bowel care programs based on their clinical differences. However, to the best of our knowledge, there have been few reports comparing bowel care pattern between the two groups and little data collected on the clinical characteristics of patients with LMNB.
Consequently, the purpose of this study was to evaluate the clinical characteristics of neurogenic bowel in patients with SCI based on the type of neurogenic bowel in order to provide better information for the development of eective bowel care programs for SCI patients.
Methods
Among 111 SCI patients who visited the Department of Physical Medicine and Rehabilitation of Ajou University Medical Center, Suwon, Korea from January 1999 and August 1999, 42 SCI patients who consented to this survey and met the following inclusion criteria were included. The inclusion criteria were as follows: (1) SCI patients who had lived at home for at least 6 months after the acute hospitalizedrehabilitation management for SCI; and (2) The Functional Independent Measure score for bowel care had to be 5 or more.
We classi®ed neurogenic bowel into two types based on the neuronal involvement. Twenty-two patients were classi®ed as UMNB and 20 patients were classi®ed as LMNB. UMNB was de®ned as when the spinal cord lesion was above the sacral level. LMNB was de®ned as when the lesion involved the sacral spinal cord, roots, or peripheral nerve innervation of the colon. All subjects with LMNB showed evidence of denervation in the bilateral lower extremities and bilateral bulbocarvernosus muscles by electrodiagnostic study.
The demographic characteristics of the subjects are presented in Table 1 . There was no signi®cant dierence in the demographic characteristics between the UMNB group and the LMNB group. The distribution according to the ASIA Impairment Scale is demonstrated in Figure 1 and no signi®cant dierence in the ASIA impairment scale was found between the two groups (P40.05).
Face-to-face interviews were conducted with the subjects on the following bowel care issues: (1) frequency of defecation; (2) frequency of fecal incontinence; (3) required time for defecation; (4) number of oral medications used for bowel care; (5) subjective diculty of bowel care on activities of daily living using visual analog scale (VAS) where 0 represented no subjective diculty and 10 represented the most severe diculty; (6) methods of bowel care; and (7) use of diet modi®cation for bowel care. The required time for bowel care was de®ned as the total time taken from initiating bowel care with suppository, digital anal stimulation, the Valsalva maneuver, enema or other methods to completing the bowel care procedure.
Independent t-testing was used to analyze the dierences between the two groups.
Results
There were signi®cant dierences between the two groups in frequency of defecation, frequency of fecal incontinence, required time for defecation, and number of oral medications used for bowel care ( Table 2 ). Five of 22 UMNB patients and 10 of 20 LMNB patients used oral pharmacological agents to facilitate their bowel care. The oral medications used for bowel care included laxatives (senna, bisacodyl or magnesium), prokinetic agents (metoclopramide, cisapride or levosulpride) or a bulk-forming agent (psyllium). Figure 2 shows the comparison of bowel care methods between the two groups. On average, each patient with UMNB used 1.86 methods for bowel care, whereas each patient with LMNB used 1.65 methods (P40.05). Among several methods of bowel care, suppositories (12 patients) were used most frequently by the UMNB group while manual anal manipulation (11 patients), the Valsalva maneuver (nine patients), and abdominal massage (six patients) were the next most frequently used methods for bowel care by the UMNB group. In the LMNB group, the Valsalva maneuver (16 patients) and manual anal manipulation (13 patients) were the two most frequently used methods. When compared with the UMNB group, suppositories and abdominal massage were used less in the LMNB group.
With regard to diet modi®cation; two patients modi®ed their diet with either high ®ber foods (one patient) or yogurt (one patient) in the UMNB group, whereas in the LMNB group, seven patients modi®ed their diet with either high ®ber foods (four patients), tea (two patients) or coee (one patient).
Discussion
According to our literature review, little descriptive data exists on the characteristics of LMNB, because most studies on neurogenic bowel excluded the LMNB group because their bowel management was often thought to be quite dierent from the UMNB group due to the dierent pathophysiology. 8, 16 Our ®ndings revealed that there were several signi®cant dierences in clinical characteristics between UMNB and LMNB, especially in frequency of defecation, frequency of fecal incontinence, required time for defecation, and number of oral medications used for bowel care. There were also dierences in the bowel care methods.
Regarding frequency of defecation, this study revealed that patients with UMNB emptied their bowels about three times a week, whereas individuals with LMNB emptied their bowels about twice a day. The previous studies 5, 16 also reported that the UMNB group emptied their bowels two to three times a week, which is consistent with our ®ndings. Among SCI patients, the LMNB group has been described as having more constipation with a high risk of incontinence due to lax external anal sphincter mechanism. The levator ani muscle is¯accid, causing the sigmoid colon and rectum to bulge below the perineum with a reduced rectal angle and thereby opening the rectal lumen, which increases the risk of incontinence. 17 Consequently, in order to avoid fecal incontinence, the LMNB group tended to perform their bowel care program about twice a day. Despite this frequent bowel care program, the LMNB group in our study experienced fecal incontinence 2.61 times per month. Fecal incontinence of this frequency has an impact on the social and emotional well-being of individuals with SCI. The fact that the LMNB group needs a twice-a-day bowel program and has a high frequency of fecal incontinence suggests that their quality of life is more negatively impacted than in the UMNB group. However, in our study, there was no signi®cant dierence in subjective diculty of bowel care on activities of daily living between the two groups. Glickman and Kamm 13 reported that SCI patients rated the magnitude of their bowel dysfunction as 5.1 with VAS in which 0 represented no perceived problems and 10 represented maximum problems. This ®nding was very similar to that of our ®ndings for the UMNB group (5.00+2.83). In our study, the required time for defecation for UMNB was 184.70+119.21 min per week, or an average of about 57.36 min per defecation, while the required time for defecation for LMNB was 395.54+425.38 min per week, or an average of about 28.98 min per defecation. Therefore, we were able to ®nd one of the possible reasons that the subjective diculty in bowel care on activities of daily living was not signi®cantly dierent for both groups. Although the LMNB group had a higher frequency of defecation than the UMNB group, their bowel program seemed to be completed within 30 min and therefore seemed to be able to tolerate such a higher frequency of defecation.
Two patients modi®ed their diet with high ®ber food (one patient) or yogurt (one patient) in UMNB group, whereas seven patients of LMNB group modi®ed their diet with high ®ber food (four patients), green tea (two patients) and coee (one patient). Interestingly, there were no published reports to show evidence that increased dietary ®ber resulted in improved bowel function in SCI patients. 2, 17 In fact, several studies have shown that increased ®ber might have opposite eects in SCI patients than that seen in able-bodied persons. Although unproven, there is likely to be some bene®t to the inclusion of a reasonable amount of ®ber in the daily diet of SCI patients and a minimum of 15 g of ®ber is recommended in the daily diet. 1 In our study, more patients with LMNB switched to high ®ber foods than those with UMNB and they reported some bene®ts with this modi®cation. Therefore, studies should be done to prove the eect of high ®ber diet on the neurogenic bowel of SCI in the near future. On the other hand,¯uid intake has a signi®cant eect on the water content of stool and in¯uences stool consis- tency. 2 However, there is no established guideline on the appropriate amount of¯uids that should be included in the diet of an individual with SCI to optimize bowel function and management. 2 Furthermore, in order to determine the appropriate amount of uids, one must take into account the type of neurogenic bowel as well as the method of bladder management. At the same time, other dietary and nutritional factors should be considered in promoting eective bowel management.
In our study, ®ve of 22 UMNB patients and 10 of 20 LMNB patients used oral pharmacological agents to facilitate their bowel care. A greater number of patients in the LMNB group used oral pharmacological agents for their bowel care, but overall, the use of oral medications was not required or necessary in the majority of patients with SCI to eectively manage their bowel. Through proper diet and¯uid management, many individuals were able to maintain adequate stool bulk and consistency without oral medications.
The most frequently used methods for the UMNB group were suppository and manual anal manipulation, while the Valsalva maneuver and manual anal manipulation were the most frequently used methods for the LMNB group. Considering the theoretical basis of this dierence, irritant suppositories would not have been eective for LMNB group because LMNB is characterized by the absence of spinalmediated re¯ex activity. 2 As we could see in our ®ndings, manual removal of stool from the rectum and the Valsalva maneuver were usually required for persons with LMNB in order to manage their bowels. Thus, some management such as the appropriate use of stool softners and/or bulk forming agents may be considered for easier digital evacuation of stool to prevent unexpected soiling. 2 We should mention that there were several methodological limitations in this study. First, this study was an interview study that mainly relied on memories of patients and their caregivers. Secondly, we could not survey the amount of ®ber and¯uid intake, which could directly in¯uence the bowel habit of patients with SCI. Despite these limitations, this study provided some descriptive data on the differences of bowel care patterns between the UMNB and the LMNB.
In conclusion, management of LMNB tends to be more problematic than that of UMNB among SCI patients. Therefore, an intensive bowel care program needs to be developed for SCI patients with LMNB.
